Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10361973
[patent_doc_number] => 20150246977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'Hybrid Light Chain Mice'
[patent_app_type] => utility
[patent_app_number] => 14/715147
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26434
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715147 | Hybrid light chain mice | May 17, 2015 | Issued |
Array
(
[id] => 10347807
[patent_doc_number] => 20150232812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'HERPES VIRUS STRAINS'
[patent_app_type] => utility
[patent_app_number] => 14/700036
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5713
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/700036 | HERPES VIRUS STRAINS | Apr 28, 2015 | Abandoned |
Array
(
[id] => 11604386
[patent_doc_number] => 20170121687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'METHODS OF CELLULAR REPROGRAMMING'
[patent_app_type] => utility
[patent_app_number] => 15/306045
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11926
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306045
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306045 | METHODS OF CELLULAR REPROGRAMMING | Apr 22, 2015 | Abandoned |
Array
(
[id] => 11436347
[patent_doc_number] => 20170037369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/305337
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 50078
[patent_no_of_claims] => 116
[patent_no_of_ind_claims] => 57
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305337 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Apr 22, 2015 | Issued |
Array
(
[id] => 11441964
[patent_doc_number] => 20170042985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHODS OF USING CYCLOOXYGENASE-PROSTACYCLIN SYNTHASE FUSION GENE'
[patent_app_type] => utility
[patent_app_number] => 15/305719
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10479
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305719 | METHODS OF USING CYCLOOXYGENASE-PROSTACYCLIN SYNTHASE FUSION GENE | Apr 21, 2015 | Abandoned |
Array
(
[id] => 10428182
[patent_doc_number] => 20150313193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'Common Light Chain Mouse'
[patent_app_type] => utility
[patent_app_number] => 14/679949
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27531
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679949
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679949 | Common Light Chain Mouse | Apr 5, 2015 | Abandoned |
Array
(
[id] => 10397453
[patent_doc_number] => 20150282460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/679951
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11151
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679951
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679951 | ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM | Apr 5, 2015 | Abandoned |
Array
(
[id] => 10372367
[patent_doc_number] => 20150257373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY'
[patent_app_type] => utility
[patent_app_number] => 14/676312
[patent_app_country] => US
[patent_app_date] => 2015-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7348
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14676312
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/676312 | MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY | Mar 31, 2015 | Abandoned |
Array
(
[id] => 10312555
[patent_doc_number] => 20150197557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'MICE THAT MAKE HEAVY CHAIN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/674211
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18692
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14674211
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/674211 | MICE THAT MAKE HEAVY CHAIN ANTIBODIES | Mar 30, 2015 | Abandoned |
Array
(
[id] => 10300203
[patent_doc_number] => 20150185203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 14/645835
[patent_app_country] => US
[patent_app_date] => 2015-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4535
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/645835 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Mar 11, 2015 | Abandoned |
Array
(
[id] => 10467183
[patent_doc_number] => 20150352198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Method of Inducing And/Or Enhancing An Immune Response to Tumor Antigens'
[patent_app_type] => utility
[patent_app_number] => 14/637415
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11236
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14637415
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/637415 | Method of Inducing And/Or Enhancing An Immune Response to Tumor Antigens | Mar 3, 2015 | Abandoned |
Array
(
[id] => 10355254
[patent_doc_number] => 20150240259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'PCP2 Mini-Promoters'
[patent_app_type] => utility
[patent_app_number] => 14/637159
[patent_app_country] => US
[patent_app_date] => 2015-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9296
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14637159
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/637159 | PCP2 Mini-Promoters | Mar 2, 2015 | Abandoned |
Array
(
[id] => 16663884
[patent_doc_number] => 10933106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => RNA viruses for immunovirotherapy
[patent_app_type] => utility
[patent_app_number] => 15/121751
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10172
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/121751 | RNA viruses for immunovirotherapy | Feb 23, 2015 | Issued |
Array
(
[id] => 15915357
[patent_doc_number] => 10654907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Methods and compositions for producing a cell expressing a T cell receptor
[patent_app_type] => utility
[patent_app_number] => 15/111639
[patent_app_country] => US
[patent_app_date] => 2015-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 30
[patent_no_of_words] => 23016
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/111639 | Methods and compositions for producing a cell expressing a T cell receptor | Jan 27, 2015 | Issued |
Array
(
[id] => 12509853
[patent_doc_number] => 10000738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Usage of odontogenic stem cells and genetically modified odontogenic stem cells
[patent_app_type] => utility
[patent_app_number] => 15/114567
[patent_app_country] => US
[patent_app_date] => 2015-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7574
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114567
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/114567 | Usage of odontogenic stem cells and genetically modified odontogenic stem cells | Jan 26, 2015 | Issued |
Array
(
[id] => 16985643
[patent_doc_number] => 11072801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Muscle-specific nucleic acid regulatory elements and methods and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/112795
[patent_app_country] => US
[patent_app_date] => 2015-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 46
[patent_no_of_words] => 24864
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/112795 | Muscle-specific nucleic acid regulatory elements and methods and use thereof | Jan 20, 2015 | Issued |
Array
(
[id] => 11128014
[patent_doc_number] => 20160324989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'METHODS FOR ENHANCING THE DELIVERY OF ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/110211
[patent_app_country] => US
[patent_app_date] => 2015-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10789
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110211 | METHODS FOR ENHANCING THE DELIVERY OF ACTIVE AGENTS | Jan 12, 2015 | Abandoned |
Array
(
[id] => 13671171
[patent_doc_number] => 20160374319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => TRANSGENIC NON-HUMAN MAMMAL THAT EXPRESSES HUMAN MMP2
[patent_app_type] => utility
[patent_app_number] => 15/103457
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103457 | Transgenic non-human mammal that expresses human MMP2 | Dec 9, 2014 | Issued |
Array
(
[id] => 9934277
[patent_doc_number] => 20150082469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'HUMANIZED IL-7 RODENTS'
[patent_app_type] => utility
[patent_app_number] => 14/551538
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8686
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14551538
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/551538 | Humanized IL-7 rodents | Nov 23, 2014 | Issued |
Array
(
[id] => 13761113
[patent_doc_number] => 10172885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Cell
[patent_app_type] => utility
[patent_app_number] => 15/037405
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 32
[patent_no_of_words] => 20500
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037405 | Cell | Nov 20, 2014 | Issued |